Pre-trained knowledge transfer with application in multisystem inflammatory syndrome subphenotyping in children

Xiaokang Liu1, Naimin Jing2, Yiwen Lu3,4

  • 1Department of Statistics and Data Science, University of Missouri, Columbia, MO, USA.

Npj Health Systems
|August 5, 2026
PubMed

Insights

This study introduces a novel framework for analyzing Multisystem Inflammatory Syndrome in Children (MIS-C) data across different studies. It effectively addresses data privacy and heterogeneity challenges to identify MIS-C subphenotypes.

Area of Science:

  • Pediatric infectious diseases
  • Computational biology
  • Epidemiology

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe post-COVID-19 condition with diverse clinical presentations.
  • Identifying MIS-C subphenotypes is crucial for risk stratification and targeted therapy development.
  • Analyzing combined data from multiple studies is ideal but hindered by privacy and heterogeneity issues.

Purpose of the Study:

  • To develop a novel framework for analyzing multisite MIS-C data without sharing patient-level information.
  • To enable knowledge transfer of pre-trained subphenotypes from large source studies to a target study.
  • To account for and explain between-study heterogeneity using study-specific mixing proportions.

Main Methods:

  • A one-shot summary statistics-based framework for knowledge transfer.
  • Utilizing pre-trained subphenotypes from large-scale source studies.
  • Employing study-specific subphenotype mixing proportions to model heterogeneity.

Main Results:

  • The proposed framework successfully transfers knowledge of shared subphenotypes across studies.
  • Study-specific mixing proportions effectively explain clinical heterogeneity between populations.
  • Simulations and MIS-C data analysis confirm the method's benefits.

Conclusions:

  • The framework offers a privacy-preserving approach for joint analysis of distributed health data.
  • It facilitates the identification of MIS-C subphenotypes even with limited target study data.
  • This method can advance understanding and treatment of MIS-C and similar complex pediatric conditions.

Related Concept Videos